Physician profile
Victoria Aphailee
NPI 1609271485
$1,095.35
in general payments reported to CMS, 2019-2025
11 companies · $88.24 in 2025
The $88.24 reported for 2025 was less than what a typical Maternal Newborn provider received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $161 · 2022: $310 · 2023: $497 · 2024: $39.36 · 2025: $88.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $610.61 | 2021-2024 | |
| Evofem Biosciences, INC. | $110.42 | 2021-2023 | Phexxi |
| Organon LLC | $95.61 | 2022-2024 | |
| Novo Nordisk INC | $67.09 | 2025 | Wegovy |
| Mayne Pharma Commercial LLC | $61.63 | 2023-2025 | |
| Exeltis, USA INC. | $48.15 | 2022-2023 | Slynd |
| Sumitomo Pharma America, INC. | $25.66 | 2023 | Myfembree |
| Pfizer INC. | $24.96 | 2022 | |
| Becton, Dickinson and Company | $17.94 | 2023 | Bd Onclarity |
| Agile Therapeutics, INC. | $17.51 | 2021 | |
| Coopersurgical, INC. | $15.77 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Aphailee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.